Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 09/01: (TRVN) (KTOS) (ALKS) Higher; (ADEP) (DLTR) (GPRO) Lower (more...)

September 1, 2015 9:30 AM
Trevena (NASDAQ: TRVN) 35.2% HIGHER; announced positive data from its randomized, double-blind, placebo- and active-controlled Phase 2b trial of TRV130 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles